67
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

, , , , &
Pages 515-519 | Published online: 02 Mar 2015

References

  • ZhouZQHuDYAn epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland ChinaJ Epidemiol200818520921618776706
  • GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
  • MariniCDe SantisFSaccoSContribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based studyStroke20053661115111915879330
  • HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
  • CammAJLipGYDe CaterinaR2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
  • JanuaryCTWannLSAlpertJS2014AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol Epub2014328
  • QiZGWangHZGaoYAntithrombotic therapy in 875 elderly patients with atrial fibrillationChinese Journal of Geriatric Heart Brain and Vessel Diseases20119805807 Chinese
  • GuoYTWuQZhangLAntithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk?Clin Interv Aging201052515716220517485
  • LipGYLarocheCDanGA‘Real-world’ antithrombotic treatment in atrial fibrillation: the EORP-AF pilot surveyAm J Med20141276519529.e124486284
  • PartingtonSLAbidSTeoKOczkowskiWO’DonnellMJPre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapyThromb Res2007120566366917434577
  • PoliDAntonucciETestaSTosettoAAgenoWPalaretiGBleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for AnticoagulationCirculation2011124782482921810658
  • TincaniEBaldiniPCrowtherMABleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillationBlood Coagul Fibrinolysis2009201475120523164
  • FribergLHammarNRosenqvistMStroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial FibrillationEur Heart J201031896797519176537
  • HohnloserSHPajitnevDPogueJIncidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyJ Am Coll Cardiol200750222156216118036454
  • OlesenJBLipGYLaneDAVascular disease and stroke risk in atrial fibrillation: a nationwide cohort studyAm J Med20121258813826
  • HansenMLSorensenRClausenMTRisk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillationArch Intern Med2010170161433144120837828
  • DewildeWJOirbansTVerheugtFWUse of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialLancet201338198721107111523415013